Cannabinoids in Neurologic and Mental Disease

• Author : Liana Fattore
• Publisher : Academic Press
• Release : 23 January 2015

The application of cannabis sativa for the treatment of neurologic and mental disease is expanding. Cannabinoids in Neurologic and Mental Disease collects and presents for the first time recent research involving the use of pharmacological cannabinoids for the treatment of neurodegenerative and neuroinflammatory disease. The neurologic application of cannabinoid therapy builds upon psychiatric and psychological use for the treatment of a variety of core mental disorders. This comprehensive reference on the known uses of cannabinoids will be useful for clinical

• Author : Elisabeth J. Van Bockstaele
• Publisher : Springer Science & Business Media
• Release : 07 July 2013

The past decade has seen tremendous growth in the study of cannabinoid receptor signaling in brain. The impact and consequences of cannabinoid modulation of monoaminergic (dopamine, norepinephrine, and serotonin) circuits is becoming more clear. Scientists have shown significant interaction between these two systems in a variety of psychiatric and neurological disorders such as affective disorders, multiple sclerosis, and pain or pain disorders. The overarching goal of Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders is to provide current information

• Author : Eric Murillo-Rodriguez,S. R. Pandi-Perumal,Jaime M. Monti
• Publisher : Springer Nature
• Release : 17 December 2020

This volume highlights the recent advances in the understanding of the endocannabinoid system and the likely benefit from the therapeutic effects of cannabinoid treatment in a variety of health issues. Archeological evidence has shown that Cannabis has a long history of use for multiple purposes, including the treatment of medical conditions. The primary active constituent of the hemp plant Cannabis sativa, delta 9-tetrahydrocannabinol (Δ9-THC), causes euphoria, enhancement of sensory perception, tachycardia, antinociception, difficulties in concentration and impairment of memory, among

• Author : Attila Köfalvi
• Publisher : Springer Science & Business Media
• Release : 22 December 2007

Endocannabinoids have tremendous therapeutic potential. This book introduces readers to our current understanding of the neurobiology of endocannabinoids and related systems, detailing their pathophysiological role and therapeutic potential. Authors, experienced clinical investigators, present and analyze results of recent clinical trials as well as the development of new therapeutic strategies and medicines.

• Author : Anonim
• Publisher : Unknown
• Release : 31 March 2023

The second edition of this text provides a comprehensive overview of the psychiatry and neuroscience of Cannabis sativa (marijuana). It outlines the very latest developments in the understanding of the human cannabinoid system, and links this knowledge to clinical and epidemiological facts about the impact of cannabis on mental health. Clinically focused chapters review not only the direct psychomimetic properties of cannabis, but also the impact consumption has on the courses of evolving or established mental illnesses such as schizophrenia.

• Author : David Castle,Robin Murray
• Publisher : Cambridge University Press
• Release : 27 May 2004

This book provides a comprehensive overview of the psychiatry and neuroscience of Cannabis sativa (marijuana), with particular emphasis on psychotic disorders. It outlines developments in our understanding of the human cannabinoid system, and links this knowledge to clinical and epidemiological facts about the impact of cannabis on mental health. Clinically focused chapters review not only the direct psychomimetic properties of cannabis, but also the impact consumption has on the courses of evolving or established mental illness such as schizophrenia. A

• Author : Michael T. Compton,Marc Manseau
• Publisher : Academic Press
• Release : 25 August 2017

The Complex Connections between Cannabis and Schizophrenia provides an in-depth overview of the current state of research into the role that cannabis plays in schizophrenia, covering both the pathophysiological and the pharmacological implications. It addresses the epidemiology of cannabis use and the risks associated with its use, the biological aspects of the drug, its effects on the brain and the pharmacological possibilities of using cannabidiol to treat schizophrenia. It is the only book on the market devoted exclusively to examining

• Author : Marco Colizzi,Sagnik Bhattacharyya
• Publisher : MDPI
• Release : 05 February 2021

Over the years, there has been increasing interest into the public health impact of cannabis use, especially by young adults. This follows the evidence of a growing prevalence of regular cannabis use worldwide, with approximately 200 million users. Recreational cannabis use, especially a frequent use of products with high levels of its main psychoactive ingredient delta-9-tetrahydrocannabinol (Δ 9-THC), can cause dependence and have transient and long-lasting detrimental mental health effects, also negatively impacting cognitive processing and brain function and metabolism. In

• Author : Attila Köfalvi
• Publisher : Springer
• Release : 01 November 2008

Endocannabinoids have tremendous therapeutic potential. This book introduces readers to our current understanding of the neurobiology of endocannabinoids and related systems, detailing their pathophysiological role and therapeutic potential. Authors, experienced clinical investigators, present and analyze results of recent clinical trials as well as the development of new therapeutic strategies and medicines.

• Author : World Health Organization. Department of Mental Health and Substance Abuse,World Health Organization,Disease Control Priorities Project
• Publisher : World Health Organization
• Release : 31 March 2023

This publication brings together five chapters from 'Disease Control Priorities in Developing Countries' (2nd ed., 2006) (ISBN 9780821361795) along with an introduction and a conclusion by WHO. The chapters cover mental disorders, neurological disorders, learning and developmental disabilities, and alcohol and illicit opiate abuse. It considers the cost-effectiveness of interventions for these specific groups of disorders, with the aim of contributing to the reformulation of policies and programmes and the reallocation of resources, eventually leading to reduction of morbidity and mortality.

• Author : John Calvin M. Brust
• Publisher : Butterworth-Heinemann
• Release : 31 March 2023

The 2nd Edition of this comprehensive text features practical guidance on how to diagnose and manage the neurological effects and complications of every major category of recreationally used drugs. Book jacket.

• Author : Wagner F. Gattaz,Geraldo Busatto Filho
• Publisher : Springer Science & Business Media
• Release : 12 November 2009

Schizophrenia remains an important challenge to psychiatry, with its causes and underlying brain mechanisms yet to be fully revealed. Currently available treatments are neither universally effective nor without unwanted effects. These aspects, together with the high prevalence of schizophrenia, its often debilitating nature, and the associated family and social burden, make this mental disorder one of the most complex public health issues of our times. The purpose of the Advances in Schizophrenia Research series is to provide comprehensive periodic reviews

• Author : Roger Roffman,Robert S. Stephens
• Publisher : Cambridge University Press
• Release : 23 February 2006

This state-of-the-science review looks at all aspects of cannabis dependence, from whether it occurs to how to prevent it.

• Author : Colin R. Martin,Vinood B. Patel,Victor R Preedy
• Publisher : Elsevier
• Release : 01 June 2023

Cannabis, Cannabinoids, and Endocannabinoids offers a comprehensive reference on natural and synthetic cannabinoids, providing coverage on both adverse and non-adverse effects, including reactivity to pain, changes in behavior and neuroactivity. This volume updates on research on the effects of these compounds in brain function and neurological dysfunction, offering readers a comprehensive reference on medical usage and the symptom relief provided by these compounds. With coverage of neurological diseases like Alzheimer’s and Parkinson’s, and a wide range of other

• Author : Colin R.N. Martin,Vinood B. Patel,Victor R. Preedy
• Publisher : Elsevier
• Release : 01 June 2023

Cannabis Use, Neurobiology, Psychology, and Treatment offers readers a comprehensive reference on neurological changes, both transient and long-term, and other factors surrounding the use of these compounds and extracts. With coverage of both natural and synthetic cannabinoids, this broad coverage allows readers to learn about both adverse and non-adverse effects, including reactivity to pain, changes in behavior, and neuroactivity. This volume provides a platform for research on the effects of these compounds in brain function and neurological dysfunction. Extracts from